Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moniek Maarse

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Heart Rhythm O2|June 16, 2023
Long-term outcomes of successful left atrial appendage occlusion with focus on stroke prevention: 10-year follow-up of a single-center registryMoniek Maarse, Errol W Aarnink, Marina F M Huijboom, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 19, 2021
Efficacy and safety of the GOLD FORCE multicentre randomized clinical trial: multielectrode phased radiofrequency vs. irrigated radiofrequency single-tip catheter with contact force ablation for treatment of symptomatic paroxysmal atrial fibrillationLisette I S Wintgens, Martijn N Klaver, Moniek Maarse, et al.
American Heart Journal|May 10, 2022
COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy"Marina Huijboom, Moniek Maarse, Errol Aarnink, et al.
JACC. Cardiovascular Interventions|May 25, 2024
Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation ContraindicationErrol W Aarnink, Moniek Maarse, Nicolai Fierro, et al.
JAMA Neurology|October 7, 2024
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite AnticoagulationMoniek Maarse, David J Seiffge, David J Werring, et al.
JACC. Cardiovascular Interventions|November 29, 2023
Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and OutcomesJules Mesnier, Trevor Simard, Richard G Jung, et al.
Journal of the American College of Cardiology|July 23, 2021
Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage OcclusionTrevor Simard, Richard G Jung, Kyle Lehenbauer, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 6, 2024
Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomesSophie Eppinger, Kerstin Piayda, Roberto Galea, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Heart Rhythm O2|June 16, 2023
Long-term outcomes of successful left atrial appendage occlusion with focus on stroke prevention: 10-year follow-up of a single-center registryMoniek Maarse, Errol W Aarnink, Marina F M Huijboom, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 19, 2021
Efficacy and safety of the GOLD FORCE multicentre randomized clinical trial: multielectrode phased radiofrequency vs. irrigated radiofrequency single-tip catheter with contact force ablation for treatment of symptomatic paroxysmal atrial fibrillationLisette I S Wintgens, Martijn N Klaver, Moniek Maarse, et al.
American Heart Journal|May 10, 2022
COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy"Marina Huijboom, Moniek Maarse, Errol Aarnink, et al.
JACC. Cardiovascular Interventions|May 25, 2024
Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation ContraindicationErrol W Aarnink, Moniek Maarse, Nicolai Fierro, et al.
JAMA Neurology|October 7, 2024
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite AnticoagulationMoniek Maarse, David J Seiffge, David J Werring, et al.
JACC. Cardiovascular Interventions|November 29, 2023
Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and OutcomesJules Mesnier, Trevor Simard, Richard G Jung, et al.
Journal of the American College of Cardiology|July 23, 2021
Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage OcclusionTrevor Simard, Richard G Jung, Kyle Lehenbauer, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 6, 2024
Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomesSophie Eppinger, Kerstin Piayda, Roberto Galea, et al.
Pageof 2